Abstract
Non-alcoholic fatty liver disease is one of the main causes of elevated liver enzymes and chronic liver disease worldwide. It ranges from steatosis to steatohepatitis, leading to cirrhosis and related liver dysfunction. Silymarin is a herbal medicine, mostly used for liver disorders owing to its supposed hepatoprotective action. This report recommends silymarin in a patient with diabetes and grade II non-alcoholic steatohepatitis, confirming significant hepatoprotective effects as shown by the reduction of liver enzyme activities.
Author supplied keywords
Cite
CITATION STYLE
Lee, Y. Y., & Tee, V. (2023). Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report. Drugs in Context, 12. https://doi.org/10.7573/dic.2023-2-10
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.